According to a recent diabetes study, seniors who take diabetes drug Avandia could face a greater risk of death and heart failure compared to those that take other, similar diabetes drugs .
A study published in the Archives of Internal Medicine, conducted in Bosto, indicates that those people aged 65 or over who took Avandia faced a 15 per cent increased risk of death after one year, not to mention a 13 per cent greater risk of heart failure.
Dr. Wolfgang Winkelmayer was reported as saying: “For men, that left an important question open. What if you happen to directly compare those two treatments together?”
The study authors reportedly concluded: “Although previous studies have indicated that the increased risk with rosiglitazone use resides predominantly in cardiovascular outcomes, the present study suggests that differences in all-cause mortality [death] risk may be even more important to consider in elderly patients.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…